When you're making the case to invest in screening services or planning for a breast center, it's critical to understand what happens downstream of screening mammography. See what we found when we looked at service utilization, including diagnostic mammograms, biopsies, and surgeries, following breast cancer screening. Read more.
In a recent conversation with one of our Advisory Board colleagues, we were struck by how pivotal cancer genetic counseling services were in her decision of where to receive her breast health care. Our members frequently ask about the best ways to demonstrate the ROI for this poorly reimbursed service, so we want to share her story and explain how it should change your breast cancer program's strategy. Read more.
When FDA approved two CAR T-cell therapies last year, it caused a groundswell of excitement across the country—but many questions remain around implementation and reimbursement. Keep reading to learn how one leading cancer center reorganized its services to improve care for immunotherapy patients and how barriers to CAR T reimbursement are raising concerns about access. Read more.
One of the most common requests we receive from cancer program leaders is for evidence on the benefits of navigation. To help you evaluate the benefits of navigation or to make the case for navigators at your facility, we've compiled a summary of recent studies on patient navigation and their findings here. Read more.
All too often, patients are not given the chance to have meaningful discussions about their wishes and desires at the end of life. Using bucket lists and other creative methods mentioned in this blog can help your cancer program overcome barriers to having these conversations with your patients. Read more.